The Expert Angle

Medlior is a well-known and trusted industry leader.

Our team is dedicated to delivering high-quality research that provides a solid basis for informed decision-making.

Medlior’s Expert Angle offers the inside track on new studies, industry hot topics, and what you need to know in the fast-paced world of clinical research, all from the point of view of the Medlior team of experts. From the latest topics and trends to the foundations of health and medical research, Medlior explores topics relevant to clients and the world.

Virtual ISPOR 2021: Burden of Disease and Current Treatment Patterns for Migraine in Canada

Virtual ISPOR 2021: Burden of Disease and Current Treatment Patterns for Migraine in Canada

E-Poster Title: Epidemiology, Treatment Landscape, and Healthcare Resource Utilization for Patients with Migraine in Canada Migraine is a common, debilitating headache disorder that is the third leading cause of global disability and the leading cause of years lived with disability (YLDs) ...
COVID Vaccines in Canada

COVID Vaccines in Canada

COVID-19 has changed the entire world. In Medlior’s latest blog post, we look at vaccine development and approval in Canada, answering questions about how the vaccines could be developed so quickly, and what contributed to Canada’s slow start in rolling them out. Looking back, we can see
Key Highlights From ISPOR 2021

Key Highlights From ISPOR 2021

The ISPOR 2021 annual conference was held last week. As usual, there were numerous insightful and thought-provoking sessions and workshops to attend, aimed at improving health economics and outcomes research (HEOR) research methods. Unsurprisingly, the COVID-19 pandemic was a common theme ...
Epidemiology, Treatment Landscape, and Healthcare Resource Utilization for Patients with Migraine in Canada: A Literature Review

Epidemiology, Treatment Landscape, and Healthcare Resource Utilization for Patients with Migraine in Canada: A Literature Review

Synthetic Data and Real-World Evidence Studies

Synthetic Data and Real-World Evidence Studies

What is Synthetic Data? Synthetic data is the generation of realistic datasets that capture important relationships and information from real-world data. These datasets are created through random sampling models, such as Bayesian or neural networks, with the help of domain experts to validate ...
COVID-19 and Opioid Overdose Deaths: Insights from Alberta’s Substance Use Surveillance Data

COVID-19 and Opioid Overdose Deaths: Insights from Alberta’s Substance Use Surveillance Data

People who use drugs, particularly opioids, are a group that has been disproportionately impacted by the COVID-19 pandemic. Safe consumption sites and homeless shelters are supports often relied upon by people who use drugs. During the pandemic, these supports have been, in some cases, ...
Medlior Publications

Medlior Publications

Explore a list of all of Medlior's recent publications including recent Medlior evidence generation publications and recent Medlior RWE publications. Recent Medlior RWE publications Scory T, Chen G, Farris M, Shih YH, Pinto L, Cowling T. Lipid-lowering therapy patterns and low-density ...
The effects of COVID-19 on Cancer screening

The effects of COVID-19 on Cancer screening

Across the globe, the COVID-19 pandemic has negatively impacted healthcare delivery including: delays in elective or non-urgent surgeries and procedures, disruptions to cancer screening, and cessation of routine laboratory tests. In Canada, the Canadian Institute for Health ...
The Canadian Survey on Disability: An Underutilized Source for Measuring Burden of Illness

The Canadian Survey on Disability: An Underutilized Source for Measuring Burden of Illness

The Canadian Survey on Disability (CSD) is a repeated cross-sectional survey of Canadians 15 years of age and older living with disability.1 Conducted by Statistics Canada, CSD participants are recruited from individuals who reported having a long-term health related condition or difficulty on ...
Report on virus-neutralizing monoclonal antibodies for the treatment of SARS-CoV-2

Report on virus-neutralizing monoclonal antibodies for the treatment of SARS-CoV-2

Medlior was pleased to work with the Canadian Agency for Drugs and Technologies in Health (CADTH) to prepare a report on virus-neutralizing monoclonal antibodies for the treatment of SARS-CoV-2 infection, as part of CADTH’s Coronavirus Disease (COVID-19) evidence bundle. The Medlior team ...
Looking Forward for 2021

Looking Forward for 2021

In January of 2020, we started the year with a passion for innovation and collaboration to produce impactful health outcomes research projects. We certainly could not have predicted the year that would follow, and while it was unprecedented, it also emphasized the vital role of health research ...
Looking back on 2020 – a year no one predicted

Looking back on 2020 – a year no one predicted

There’s not much that can be said about 2020 that hasn’t already been said. Unpredictable, unprecedented, unparalleled, 2020 will be remembered for a lot of things. But as we look towards 2021, we’re seeing hope like we haven’t seen in many months. With vaccines getting approved from Pfizer,